Video Lectures
State-of-the-industry video lectures by leading urology experts
Latest Videos

ORLANDO, FL USA (UroToday.com) - Given the significance of second harmonic generation (SHG)-based optical biomarkers in various cancers—including ovarian and breast cancer—these authors sought to examine whether this application might also be useful in renal cell carcinoma (RCC). Previous analyses have demonstrated subjective differences in intrinsic collagen signals between malignant and benign renal tissue, while improvements in digital analytic technology and software allow for quantification of SHG-based optical biomarkers, in order to develop an “SHG signature” predicting RCC prognosis and outcomes.

auaThe authors developed a tissue microarray (TMA) using small (0.6 mm) cores of renal tissue specimens of various grades (RCCs grades 1–4, benign tissue). After preparing and staining (H&E) five μm sections of the TMA, the authors captured bright-field and SHG images. These images were then analyzed using CT-FIRE software, which sensitively characterizes changes in collagen angle, thickness, and length.

The renal tissue specimens (benign and malignant) all generated excellent SHG signals from the collagen fibers. The small samples used in the microarray are analogous in size to a renal tumor biopsy. Software analysis of the images quantified collagen fiber width, straightness, length, and fiber angle. Quantification results demonstrated significantly increased alignment of collagen fibers with higher-grade disease, while bright-field images demonstrate qualitative fiber alignment.

The authors conclude that “SHG imaging provides a flexible platform” for renal tumor analysis, and it might serve as a useful adjunct in better characterizing both whole specimens and biopsy cores. Future studies are necessary to link these collagen-based optical biomarkers with RCC patient outcomes, while other analyses are necessary to further elucidate the role of collagen in RCC progression.

Presented by Sara Best at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

University of Wisconsin, Madison, WI USA

Written by Eric Ballon-Landa, BA, University of California (Irvine), and medical writer for UroToday.com

 

Calendar
Upcoming urology industry events
August 1-5, 2018 / Sheraton Philadelphia Society Hill Hotel
SUFU Research Foundation Resident Preceptorship 2018
August 3-4, 2018 / Hyatt Regency Washington on Capitol Hill
Best of ASCO 2018 - Washington, DC
August 10-11, 2018 / The Palmer House Hilton, Chicago, IL
Best of ASCO 2018 - Chicago, IL
August 28-31, 2018 / ICS 2018
International Continence Society 2018
Journals
Print publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 2 Issue 4

Everyday Urology™ - Oncology Insights

From the Editor

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor